Position in NUVB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,935,393
+$5,032,879 QoQ
Shares Held
2,277,358
+23.6% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#17
of 242 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. NUVB ranks #16 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in NUVB
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,935,393 | 2,277,358 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,902,514 | 1,842,078 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,608,327 | 291,108 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,523,271 | 781,165 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,769,197 | 1,005,226 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,318,107 | 871,469 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $659,952 | 288,189 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,245,680 | 426,603 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $407,563 | 111,968 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $101,321 | 67,100 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $434,746 | 324,438 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $572,430 | 318,017 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $527,908 | 318,017 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $386,835 | 201,477 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $350,262 | 156,367 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $120,754 | 37,270 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $72,856 | 13,851 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||